Data / Form D filings / AccuVein Inc.
AccuVein Inc.: Form D filings
AccuVein Inc., a health care company in Medford, NY, filed 13 Form D notices with the SEC between 2011 and 2023. The latest, on February 10, 2023, reports $5.3 million sold of a $5.4 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3243 ROUTE 112, BUILDING 1, SUITE 2, Medford, NY, 11763
- Phone
- (631) 367-0393
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1526868
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Amendment | $5,400,000 | $5,306,083 | $93,917 | 25 | Jan 30, 2023 | sec.gov |
| Feb 10, 2023 | New notice | $5,400,000 | $3,097,814 | $2,302,186 | 20 | Jan 30, 2023 | sec.gov |
| Apr 8, 2022 | Amendment | $18,293,520 | $17,296,753 | $996,767 | 36 | Jul 31, 2020 | sec.gov |
| Oct 28, 2020 | Amendment | $13,793,524 | $13,793,524 | 36 | Jul 31, 2020 | sec.gov | |
| Sep 8, 2020 | New notice | $12,000,000 | $5,383,604 | $6,616,396 | 4 | Jul 31, 2020 | sec.gov |
| May 12, 2020 | New notice | $2,547,338 | $2,547,338 | 33 | Apr 28, 2020 | sec.gov | |
| Nov 15, 2019 | New notice | $2,133,000 | $2,000,018 | $132,982 | 33 | Oct 31, 2019 | sec.gov |
| Feb 12, 2018 | New notice | $10,000,000 | $8,000,000 | $2,000,000 | 40 | Jan 31, 2018 | sec.gov |
| Jan 2, 2018 | Amendment | $2,900,846 | $2,900,846 | 11 | Sep 25, 2017 | sec.gov | |
| Nov 13, 2017 | New notice | $1,400,000 | $1,400,000 | 6 | Sep 25, 2017 | sec.gov | |
| Dec 2, 2016 | New notice | $9,050,000 | $2,455,008 | $6,594,992 | 28 | Nov 16, 2016 | sec.gov |
| Oct 27, 2011 | Amendment | $23,461,510 | $23,461,510 | 62 | Jul 27, 2011 | sec.gov | |
| Aug 2, 2011 | New notice | $22,961,510 | $22,961,510 | 59 | Jul 27, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Heather Rohan | Director | |
| Brian Verrier | Director | |
| Kevin McArdle | Executive Officer | |
| Christopher Hutchison | Executive Officer, Director | |
| Akhilesh Pathipati | Director | |
| Stephen Reeders | Director | |
| James Lackie | Director |
Other health care companies in New York that filed recently
- MOCEAN HOLDINGS Corp $1.5 million · Oct 27, 2026
- Frictionworx Inc. $40,000 · Oct 13, 2026
- Atmos Clinic, Inc. $6 million · Oct 8, 2026
- PreciseDx, Inc. $3.7 million · Oct 7, 2026
- Amani Therapeutics, Inc. $35 million · Oct 1, 2026
- Click Therapeutics, Inc. $50 million · Oct 1, 2026
Every Form D from the week of Feb 6, 2023 · All recent filings in New York · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what AccuVein Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.